These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26418594)

  • 21. Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial.
    Simpson HB; Gorfinkle KS; Liebowitz MR
    J Clin Psychiatry; 1999 Sep; 60(9):584-90. PubMed ID: 10520976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential efficacy of cognitive-behavioral therapy and pharmacological treatments for pediatric obsessive-compulsive disorder: a meta-analysis.
    Sánchez-Meca J; Rosa-Alcázar AI; Iniesta-Sepúlveda M; Rosa-Alcázar A
    J Anxiety Disord; 2014 Jan; 28(1):31-44. PubMed ID: 24334214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obsessive-compulsive disorder: strategies for using CBT and pharmacotherapy.
    Storch EA; Merlo LJ
    J Fam Pract; 2006 Apr; 55(4):329-33. PubMed ID: 16608672
    [No Abstract]   [Full Text] [Related]  

  • 24. Predictors associated with improved cognitive-behavioral therapy outcome in pediatric obsessive-compulsive disorder.
    Torp NC; Dahl K; Skarphedinsson G; Compton S; Thomsen PH; Weidle B; Hybel K; Valderhaug R; Melin K; Nissen JB; Ivarsson T
    J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):200-207.e1. PubMed ID: 25721185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A Review and Recommendations of Evidence-Based Treatments for Pediatric Obsessive-Compulsive Disorder].
    Skarphedinsson G; Lauth B; Njardvik U; Ivarsson T
    Laeknabladid; 2016 Apr; 102(4):179-85. PubMed ID: 27197125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-Effectiveness of Treatment Alternatives for Treatment-Refractory Pediatric Obsessive-Compulsive Disorder.
    Gregory ST; Kay B; Riemann BC; Goodman WK; Storch EA
    J Anxiety Disord; 2020 Jan; 69():102151. PubMed ID: 31864218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of obsessive-compulsive disorder in children and adolescents].
    Højgaard DRMA; Nissen JB; Hybel KA; Thomsen PH
    Ugeskr Laeger; 2019 Jun; 181(23):. PubMed ID: 31267938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of obsessive-compulsive disorders: recommendations of the revised S3 guidelines on obsessive-compulsive disorders].
    Voderholzer U; Favreau M; Rubart A; Staniloiu A; Wahl-Kordon A; Zurowski B; Kathmann N
    Nervenarzt; 2022 Jul; 93(7):678-687. PubMed ID: 35763051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcome in patients with obsessive-compulsive disorder after discontinuation of SRI treatment: results from a two-year follow-up.
    Kordon A; Kahl KG; Broocks A; Voderholzer U; Rasche-Räuchle H; Hohagen F
    Eur Arch Psychiatry Clin Neurosci; 2005 Feb; 255(1):48-50. PubMed ID: 15538591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How resistant is 'treatment-resistant' obsessive-compulsive disorder in youth?
    Krebs G; Isomura K; Lang K; Jassi A; Heyman I; Diamond H; Advani J; Turner C; Mataix-Cols D
    Br J Clin Psychol; 2015 Mar; 54(1):63-75. PubMed ID: 25130442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maximizing remission from cognitive-behavioral therapy in medicated adults with obsessive-compulsive disorder.
    Simpson HB; Foa EB; Wheaton MG; Gallagher T; Gershkovich M; Schmidt AB; Huppert JD; Campeas RB; Imms PA; Cahill SP; DiChiara C; Tsao SD; Puliafico AC; Chazin D; Asnaani A; Moore K; Tyler J; Steinman SA; Sanchez-LaCay A; Capaldi S; Snorrason I; Turk-Karan E; Vermes D; Kalanthroff E; Pinto A; Hahn CG; Xu B; Van Meter PE; Katechis M; Scodes J; Wang Y
    Behav Res Ther; 2021 Aug; 143():103890. PubMed ID: 34089924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: What moderates improvement?
    Wheaton MG; Rosenfield D; Foa EB; Simpson HB
    J Consult Clin Psychol; 2015 Oct; 83(5):926-937. PubMed ID: 26009783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Commonly asked questions in the treatment of obsessive-compulsive disorder.
    Arumugham SS; Reddy YC
    Expert Rev Neurother; 2014 Feb; 14(2):151-63. PubMed ID: 24372473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of obsessive-compulsive disorder in children and adolescents.
    Boileau B
    Dialogues Clin Neurosci; 2011; 13(4):401-11. PubMed ID: 22275846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders.
    Denys D
    Psychiatr Clin North Am; 2006 Jun; 29(2):553-84, xi. PubMed ID: 16650723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment and management of treatment-refractory obsessive-compulsive disorder in children.
    Bloch MH; Storch EA
    J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):251-62. PubMed ID: 25791142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A META-ANALYSIS OF COGNITIVE BEHAVIOR THERAPY AND MEDICATION FOR CHILD OBSESSIVE-COMPULSIVE DISORDER: MODERATORS OF TREATMENT EFFICACY, RESPONSE, AND REMISSION.
    McGuire JF; Piacentini J; Lewin AB; Brennan EA; Murphy TK; Storch EA
    Depress Anxiety; 2015 Aug; 32(8):580-93. PubMed ID: 26130211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder.
    Fineberg NA; Baldwin DS; Drummond LM; Wyatt S; Hanson J; Gopi S; Kaur S; Reid J; Marwah V; Sachdev RA; Pampaloni I; Shahper S; Varlakova Y; Mpavaenda D; Manson C; O'Leary C; Irvine K; Monji-Patel D; Shodunke A; Dyer T; Dymond A; Barton G; Wellsted D
    Int Clin Psychopharmacol; 2018 Nov; 33(6):334-348. PubMed ID: 30113928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outpatient Treatment Patterns of Pediatric Obsessive-Compulsive Disorder.
    Smith JL; McBride NM; Storch EA
    J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):509-515. PubMed ID: 28375695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive-compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trial.
    Skarphedinsson G; Weidle B; Thomsen PH; Dahl K; Torp NC; Nissen JB; Melin KH; Hybel K; Valderhaug R; Wentzel-Larsen T; Compton SN; Ivarsson T
    Eur Child Adolesc Psychiatry; 2015 May; 24(5):591-602. PubMed ID: 25239489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.